RANDOMIZED OPEN LABEL CROSS-OVER STUDY TO EVALUATE PHARMACOKINETICS AND SAFETY OF SINGLE INHALED DOSES OF ABEDITEROL AND AZD7594 GIVEN ALONE, IN FIXED DOSE COMBINATION (FDC) AND IN FREE COMBINATION, USING DPI, IN MALE HEALTHY VOLUNTEERS
Latest Information Update: 05 Jul 2018
At a glance
- Drugs Abediterol (Primary) ; Abediterol/Velsecorat (Primary) ; Velsecorat (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus First in man; Pharmacokinetics
- Sponsors AstraZeneca
- 23 May 2018 Results presented at the 114th International Conference of the American Thoracic Society
- 11 Apr 2017 Status changed from active, no longer recruiting to completed.
- 31 Jan 2017 Status changed from recruiting to active, no longer recruiting.